Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Verastem, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 80 | 61 | −19 |
| SharesConverted for a 1-for-12 split | 8.14M | 16.1M | +7.99M (+98.2%) |
| Value | $40.5M | $119.9M | +$79.4M (+195.7%) |
New holders (15)
Institutions that held Verastem, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,538,461 | $11.4M | 0.24% |
| Vivo Capital, LLC | 1,538,461 | $11.4M | 1.37% |
| Tang Capital Management LLC | 1,140,000 | $8.48M | 1.25% |
| Adage Capital Partners GP, L.L.C. | 600,000 | $4.46M | 0.01% |
| Soleus Capital Management, L.P. | 520,369 | $3.87M | 0.43% |
| Acuta Capital Partners, LLC | 300,000 | $2.23M | 1.51% |
| Alyeska Investment Group, L.P. | 156,762 | $1.17M | 0.01% |
| Ghisallo Capital Management LLC | 150,000 | $1.12M | 0.13% |
| AlphaCentric Advisors LLC | 150,000 | $1.12M | 0.62% |
| Maven Securities LTD | 120,463 | $896.2K | 0.13% |
| Opaleye Management Inc. | 102,000 | $758.9K | 0.18% |
| Rokos Capital Management LLP | 30,000 | $225.0K | 0.00% |
| Squarepoint Ops LLC | 15,293 | $113.8K | 0.00% |
| Tower Research Capital LLC (TRC) | 9,944 | $74.0K | 0.00% |
| Rhumbline Advisers | 674 | $5.01K | 0.00% |
Sold out (34)
Institutions that held Verastem, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.